journal article·2025-12Open access

Dual–magnetically driven nanozymes for glioblastoma immunotherapy via magnetothermal and NIR–amplified ferroptosis and apoptosis

Hui Liu, Xiaochuan Yang, Xianwen Liang, Ying Xia

Abstract

The hindrance posed by the blood-brain barrier (BBB) and the unique characteristics of the tumor microenvironment (TME) remain major challenges in glioblastoma (GBM) therapy. Here, we developed a dual-magnetically driven ultrasmall Mo 0.2 Fe 2.8 O 4 @CeO x /FA (MFCF) nanozyme exhibiting multienzyme catalytic activities for targeted synergistic therapy of GBM. This nanozyme demonstrated dual responsiveness to alternating magnetic fields (AMF) and static magnetic fields, synergized with folic acid (FA)–mediated molecular targeting to enhance BBB penetration and achieve high-precision GBM localization. Upon simultaneous exposure to AMF and near-infrared (NIR) laser irradiation, MFCF amplified reactive oxygen species (ROS) generation, depleted glutathione, and alleviated hypoxia through synergistic magnetothermal effects, type-II photodynamic therapy, and its intrinsic multienzyme catalytic activities, ultimately inducing both ferroptosis and apoptosis. Notably, this hybrid cell-death pathway triggered immunogenic cell death, promoting the proliferation and differentiation of T cells and thereby achieving systemic immune activation. Concurrently, it reprogrammed M2-polarized macrophages into pro-inflammatory M1 phenotypes, remodeling the immunosuppressive TME and enhancing antitumor immunotherapy. Furthermore, the excellent superparamagnetism of MFCF enabled T 2 -weighted magnetic resonance imaging (MRI)-guided treatment monitoring. Overall, this work presents a multifunctional nanoplatform that overcomes BBB and TME barriers to enable precise, immunomodulatory therapy for GBM.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. Peptide-drug conjugates repolarize glioblastoma-associated macrophages to resensitize chemo-immunotherapy of glioblastoma10.1126/sciadv.adr8841 ↗
2. Noninvasive activation of local and systemic immunity with a sequential-targeting sonodynamic nanovaccine to Treat glioblastoma10.1021/acsnano.5c08928 ↗
3. Immunotherapy for glioblastoma: current state, challenges, and future perspectives10.1038/s41423-024-01226-x ↗
4. D-type neuropeptide decorated AIEgen/RENP hybrid nanoprobes with light-driven ROS generation ability for NIR-II fluorescence imaging-guided through-skull photodynamic therapy of gliomas10.1002/agt2.396 ↗
5. Hierarchically engineered self-adaptive nanoplatform guided intuitive and precision interventions for deep-seated glioblastoma10.1021/acsnano.4c11006 ↗
6. Enhancing magnetic hyperthermia efficacy through targeted heat shock protein 90 inhibition: unveiling immune-mediated therapeutic synergy in glioma treatment10.1021/acsnano.4c03887 ↗
7. Research progress on nanoplatforms and nanotherapeutic strategies in treating glioma10.1021/acs.molpharmaceut.1c00856 ↗
8. Engineering biocompatible hydrogen titanate nanocarriers with blood brain barrier (BBB) crossing potential for doxorubicin delivery to glioma cells10.1039/D5NR00126A ↗
9. Y. Zhou, F. Zhu, Y. Liu, M. Zheng, Y. Wang, D. Zhang, Y. Anraku, Y. Zou, J. Li, H. Wu, X. Pang, W. Tao, O. Shimoni, A.I. Bush, X. Xue, B. Shi, Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy, Sci. Adv. 6(41) eabc7031. https://doi.org/10.1126/sciadv.abc7031.10.1126/sciadv.abc7031 ↗
10. Focused ultrasound/microbubbles-assisted BBB opening enhances LNP-mediated mRNA delivery to brain10.1016/j.jconrel.2022.05.042 ↗
11. Transmigration of magnetite nanoparticles across the blood–brain barrier in a rodent model: influence of external and alternating magnetic fields10.1039/D2NR02210A ↗
12. BBB-penetrating magnetoelectric nanoparticles with sustainable Gel formulation for enhanced chemotherapy and reduced postoperative glioma recurrence10.1016/j.cej.2024.154208 ↗
13. Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain10.1016/j.jconrel.2020.01.009 ↗
14. Evolution of magnetic hyperthermia for glioblastoma multiforme therapy10.1021/acschemneuro.8b00652 ↗
15. Biomedicine meets nanozyme catalytic chemistry10.1016/j.ccr.2023.215245 ↗
16. Engineering charge density in s-block potassium single-atom nanozyme for amplified ferroptosis in glioblastoma therapy
17. “Spark” PtMnIr nanozymes for electrodynamic-boosted multienzymatic tumor immunotherapy10.1002/adma.202308747 ↗
18. Recent advances in the bioactive structure and application of single-atom nanozymes10.26599/NBE.2023.9290047 ↗
19. Nanozyme with dual enzyme activity mediating cascade catalytic therapy synergize multiple functions for antitumor therapy
20. Cascade Co8FeS8@Co1-xS nano-enzymes trigger efficiently apoptosis-ferroptosis combination tumor therapy10.1016/j.jcis.2024.01.153 ↗
21. Synthesis-temperature-regulated multi-enzyme-mimicking activities of ceria nanozymes10.1039/D1TB00964H ↗
22. Magnetically and optically powered nanozymes: boosting breast cancer therapy with magnetothermodynamic-enhanced ferroptosis and apoptosis10.1016/j.cej.2025.161353 ↗
23. A mitochondria-targeting magnetothermogenic nanozyme for magnet-induced synergistic cancer therapy10.1016/j.biomaterials.2020.120079 ↗
24. Magnetoresponsive nanozyme: magnetic stimulation on the nanozyme activity of iron oxide nanoparticles10.1007/s11427-020-1907-6 ↗
25. ROS-responsive self-degradable DNA nanogels for targeted anticancer drug delivery10.1021/acsmacrolett.3c00442 ↗
26. Self-assembled metal-phenolic nanocomplexes comprised of green tea catechin for tumor-specific ferroptosis
27. Innate tumor-targeted nanozyme overcoming tumor hypoxia for cancer theranostic use10.1016/j.jare.2021.02.004 ↗
28. A photothermal-responsive multi-enzyme nanoprobe for ROS amplification and glutathione depletion to enhance ferroptosis10.1016/j.bios.2025.117384 ↗
29. MCL1 inhibitor augmented the anti-glioma efficacy of paclitaxel utilizing a multifunctional cascade nanodrug system10.1002/adfm.202414499 ↗
30. Self-cycling redox nanoplatform in synergy with mild magnetothermal and autophagy inhibition for efficient cancer therapy10.1016/j.nantod.2022.101374 ↗
31. Regulating the H2O2 activation pathway on a well-defined CeO2 nanozyme allows the entire steering of its specificity between associated enzymatic reactions10.1021/acsnano.3c05409 ↗
32. Next-generation of a Fe-Ce double variable-valence metals modulated high-efficiency nanozyme10.1016/j.cej.2024.153314 ↗
33. Janus nanobullets combine photodynamic therapy and magnetic hyperthermia to potentiate synergetic anti-metastatic immunotherapy
34. A magneto-optical nanoplatform for multimodality imaging of tumors in mice10.1021/acsnano.9b01436 ↗
35. Iron oxide nanoflowers@CuS hybrids for cancer tri-therapy: interplay of photothermal therapy, magnetic hyperthermia and photodynamic therapy10.7150/thno.30238 ↗
36. Glucose oxidase-loaded MnFe2O4 nanoparticles for hyperthermia and cancer starvation therapy10.1021/acsanm.2c04960 ↗
37. Mild magnetic hyperthermia-activated innate immunity for liver cancer therapy10.1021/jacs.1c02537 ↗
38. Targeted delivery of active sites by oxygen vacancy-engineered bimetal silicate nanozymes for aggregation-potentiated catalytic therapy10.1021/acsnano.3c08780 ↗
39. Catalyzing generation and stabilization of oxygen vacancies on CeO2-x nanorods by Pt nanoclusters as nanozymes for catalytic therapy10.1002/adhm.202302056 ↗
40. Modulating nanozyme-based nanomachines via microenvironmental differential photothermal therapy of orthotopic gliomas10.1002/advs.202204937 ↗
41. Synergizing catalysis with post-catalysis pseudo-iron release by building dynamic catalytic active sites in diatomic nanozymes for boosting cancer therapy10.1021/jacs.5c03804 ↗
42. Nickel atom-clusters nanozyme for boosting ferroptosis tumor therapy
43. A self-assembling nanoplatform for pyroptosis and ferroptosis enhanced cancer photoimmunotherapy10.1038/s41377-024-01673-1 ↗
44. 2D catalytic nanozyme Enables cascade enzyodynamic effect-boosted and Ca2+ overload-induced synergistic ferroptosis/apoptosis in tumor10.1002/adma.202312316 ↗
45. Metallopolysaccharide-based smart nanotheranostic for imaging-guided precise phototherapy and sequential enzyme-activated ferroptosis10.1021/acs.biomac.2c00018 ↗
46. “Balloon-like” biomimetic erythrocyte vesicles potentiate photodynamic therapy for inducing immunogenic cell death10.1016/j.cej.2024.157406 ↗
47. Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death10.1038/s41467-020-19970-9 ↗
48. Spatial isolation of single copper(I) sites for cascade Enzyme-like catalysis and simultaneous ferroptosis/cuproptosis boosted immunotherapy
49. Nano delivery of chemotherapeutic ICD inducers for tumor immunotherapy10.1002/smtd.202201307 ↗
50. Nanoparticle-based taditional chinese medicine for immunotherapy in gastrointestinal tumors10.26599/NBE.2025.9290115 ↗
51. Quasi Fe MIL-53 nanozyme inducing ferroptosis and immunogenic cell death for cancer immunotherapy10.1038/s41467-025-57542-x ↗
52. Cobalt single-atom intercalation in molybdenum disulfide enhances piezocatalytic and enzyodynamic activities for advanced cancer therapeutics10.1002/advs.202415485 ↗
53. Engineering nanozyme immunomodulator with magnetic targeting effect for cascade-enzyodynamic and ultrasound-reinforced metallo-immunotherapy in prostate carcinoma10.1038/s41467-025-57190-1 ↗
54. Rational design of single-atom nanozymes for combination cancer immunotherapy10.1002/adfm.202416563 ↗
55. Biosafety of mesoporous silica nanoparticles; towards clinical translation10.1016/j.addr.2023.115049 ↗